Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Revenue

In the fiscal year ending June 30, 2024, Kazia Therapeutics had annual revenue of 2.48M AUD with 248,000.00% growth. Kazia Therapeutics had revenue of 2.48M in the half year ending June 30, 2024.

• Revenue (ttm): 2.48M AUD
• Revenue Growth: +248,000.00%
• P/S Ratio: 2.29
• Revenue / Employee: 275,667 AUD
• Employees: 9
• Market Cap: 6.01M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	2.48M	2.48M	248,000.00%
Jun 30, 2023	1,000.00	-9.00K	-90.00%
Jun 30, 2022	10.00K	-15.17M	-99.93%
Jun 30, 2021	15.18M	14.19M	1,436.54%
Jun 30, 2020	988.11K	-451.89K	-31.38%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.